Chad R. Ritch MD, MBA

Dr. Ritch is a fellowship-trained Urologic Oncologist, and currently an Assistant Professor of Urology at the University of Miami, Miller School of Medicine. His clinical interests include the treatment of prostate, bladder, kidney and testicular cancer. His research interests are in prostate and bladder cancer and he serves as PI for a pilot trial investigating the role of nutrition intervention in patients undergoing radical cystectomy. He is a member of the AUA Guideline Panel for the Management of Non-muscle Invasive Bladder Cancer. He did his undergraduate studies at Duke University and then matriculated at the University of Chicago, where he obtained a joint degree in medicine (MD) and business (MBA) from the Pritzker School of Medicine and Booth School of Business. He then completed his residency in Urology at Columbia University Medical Center/NY Presbyterian Hospital followed by a two-year fellowship in Urologic Oncology at Vanderbilt University Medical Center.Dr. Ritch is a fellowship-trained Urologic Oncologist, and currently an Assistant Professor of Urology at the University of Miami, Miller School of Medicine. His clinical interests include the treatment of prostate, bladder, kidney and testicular cancer. His research interests are in prostate and bladder cancer and he serves as PI for a pilot trial investigating the role of nutrition intervention in patients undergoing radical cystectomy. He is a member of the AUA Guideline Panel for the Management of Non-muscle Invasive Bladder Cancer. He did his undergraduate studies at Duke University and then matriculated at the University of Chicago, where he obtained a joint degree in medicine (MD) and business (MBA) from the Pritzker School of Medicine and Booth School of Business. He then completed his residency in Urology at Columbia University Medical Center/NY Presbyterian Hospital followed by a two-year fellowship in Urologic Oncology at Vanderbilt University Medical Center.